🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
587 medicines starting with “L”
MedicineActive substanceLicence holderStatus
Lamictal 5 mg chewable/dispersible tablets
PPA0465/092/005
Lamotrigine PCO Manufacturing Ltd.
Lamictal 50 mg chewable/dispersible tablets
PA1077/061/008
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 50 mg chewable/dispersible tablets
PPA0465/443/002
Lamotrigine PCO Manufacturing Ltd.
Lamictal 50 mg chewable/dispersible tablets.
PPA1463/066/001
Lamotrigine IMED Healthcare Ltd.,
Lamictal 50 mg tablets
PA1077/061/002
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 50 mg tablets
PPA0465/092/012
Lamotrigine PCO Manufacturing Ltd.
Lamictal 50 mg tablets
PPA1463/066/008
Lamotrigine IMED Healthcare Ltd.,
Lamisil 1% w/w cream
PPA0465/151/001
Terbinafine hydrochloride PCO Manufacturing Ltd.
Lamisil 1% w/w cream
PPA1463/192/001
Terbinafine hydrochloride IMED Healthcare Ltd.,
Lamisil 1% w/w Cream
PA22650/009/001
Terbinafine hydrochloride Karo Pharma AB Marketed
Lamisil 250 mg tablets
PA0896/015/001
Terbinafine Novartis Ireland Limited Not marketed
Lamisil 250 mg tablets
PPA0465/096/001
Terbinafine PCO Manufacturing Ltd.
Lamisil 250 mg tablets
PPA1463/157/001
Terbinafine IMED Healthcare Ltd.,
Lamisil AT Cream
PA22650/009/002
Terbinafine hydrochloride Karo Pharma AB Marketed
Lamisil Once 1% cutaneous solution
PA22650/009/003
Terbinafine Karo Pharma AB Marketed
Lamivudine Teva 100 mg film-coated tablets
EU/1/09/566/1-5
Lamivudine Teva Pharma B.V.
Lamivudine Teva Pharma B.V. 150 mg film-coated tablets
EU/1/09/596/1-7
Lamivudine Teva Pharma B.V.
Lamivudine Teva Pharma B.V. 300 mg film-coated tablets
EU/1/09/596/8-14
Lamivudine Teva Pharma B.V.
Lamotrigine Desitin 10 mg/ml Oral Suspension
PA0815/004/001
Lamotrigine Desitin Arzneimittel GmbH Not marketed
Lamotrigine Desitin 5mg/ ml Oral Suspension
PA0815/006/001
Lamotrigine Desitin Arzneimittel GmbH Not marketed
Lamotrigine SyriMed 5mg/ml Oral Suspension
PA22697/018/001
Lamotrigine Syri Pharma Limited t/a Thame Laboratories Not marketed
Lamzede 10 mg powder for solution for infusion
EU/1/17/1258/001-003
Velmanase alfa Chiesi Farmaceutici S.p.A.
Lanoxin 250 microgram Tablets
PA1691/001/004
Digoxin Aspen Pharma Trading Limited Marketed
Lanoxin 500 micrograms/2 ml Solution for Injection
PA1691/001/001
Digoxin Aspen Pharma Trading Limited Not marketed
Lanoxin PG 50 micrograms/ml Elixir
PA1691/001/002
Digoxin Aspen Pharma Trading Limited Marketed
Lanoxin PG 62.5 microgram Tablets
PA1691/001/003
Digoxin Aspen Pharma Trading Limited Marketed
Lanreotide SUN 120 mg solution for injection in a pre-filled syringe
PA2050/009/003
Lanreotide Sun Pharmaceutical Industries Europe B.V. Not marketed
Lanreotide SUN 60 mg solution for injection in a pre-filled syringe
PA2050/009/001
Lanreotide Sun Pharmaceutical Industries Europe B.V. Not marketed
Lanreotide SUN 90 mg solution for injection in a pre-filled syringe
PA2050/009/002
Lanreotide Sun Pharmaceutical Industries Europe B.V. Not marketed
Lanreotide Viatris 120 mg solution for injection in a pre-filled syringe
PA23266/012/003
Lanreotide Viatris Limited Not marketed
Lanreotide Viatris 60 mg solution for injection in a pre-filled syringe
PA23266/012/001
Lanreotide Viatris Limited Not marketed
Lanreotide Viatris 90 mg solution for injection in a pre-filled syringe
PA23266/012/002
Lanreotide Viatris Limited Not marketed
Lansoprazole 15 mg gastro-resistant capsules, hard
PA2315/128/001
Lansoprazole Accord Healthcare Ireland Ltd. Marketed
Lansoprazole 30 mg gastro-resistant capsules, hard
PA2315/128/002
Lansoprazole Accord Healthcare Ireland Ltd. Marketed
Lansoprazole Krka 15 mg Gastro-resistant Capsules, hard
PA1347/062/001
Lansoprazole KRKA, d.d., Novo mesto Marketed
Lansoprazole Krka 30 mg Gastro-resistant Capsules, hard
PA1347/062/002
Lansoprazole KRKA, d.d., Novo mesto Marketed
Lansoprazole Pinewood 15mg Gastro-resistant Capsules, Hard
PA0281/151/001
Lansoprazole Pinewood Laboratories Ltd Marketed
Lansoprazole Pinewood 30mg Gastro-resistant Capsules, Hard
PA0281/151/002
Lansoprazole Pinewood Laboratories Ltd Marketed
Lansoprazole Teva Pharma 15 mg gastro-resistant capsules, hard
PA1986/008/001
Lansoprazole Teva B.V. Marketed
Lansoprazole Teva Pharma 30 mg gastro-resistant capsules, hard
PA1986/008/002
Lansoprazole Teva B.V. Marketed
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/005
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/006
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/007
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/001
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/002
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/003
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/004
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen
EU/1/00/134/030-037
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lanvis 40mg Tablets
PA1691/006/001
Tioguanine Aspen Pharma Trading Limited Not marketed
Lanzol 15 mg hard gastro-resistant capsules
PA0711/067/001
Lansoprazole Rowex Ltd Not marketed
1 2 3 4 5
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.